DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Bonaca MP, Nault P, Giugliano RP. , et al.
Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 Inhibition in subjects with elevated risk).
Circulation 2018;
137 (04) 338-350
We do not assume any responsibility for the contents of the web pages of other providers.